A lot is happening in TIPTOP, and I’m thrilled to be able share where we are and where we’re headed in partnership with Ministries of Health (MOHs) and Unitaid! As our focus countries in sub-Saharan Africa continue their efforts to introduce community intermittent preventive treatment (C-IPTp), I’m reminded of the magnitude of TIPTOP and what this project will mean for pregnant women and their unborn babies, not only in the target countries but also across the region. Denikary Pascal, a community leader from Madagascar, sums this up perfectly below.
An underpinning of TIPTOP is the integral link between research, implementation—including routine monitoring—and availability of quality assured sulfadoxine-pyrimethamine (SP). Across each country, baseline household surveys (HHS) in the project areas are providing up to date information about key factors influencing malaria in pregnancy prevention including: IPTp coverage, timing of the first IPTp dose and antenatal care attendance. The infographic below highlights key elements of the HHS process across countries.
As our journey continues, stay tuned to learn more about how each TIPTOP country is paving the way by generating critical malaria in pregnancy evidence for the World Health Organization and setting the stage for long-term sustainability of life-saving programs.